X4 Pharmaceuticals Inc (XFOR)
NASDAQ
Quarter End | 9 2022 | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総資産 | 113.41M | 155.59M | 124.41M | 173.4M | 173.29M | 147.26M | 112.18M | 210.61M |
流動資産合計 | 85.72M | 128.68M | 98.22M | 147.65M | 147.87M | 122.08M | 87.33M | 175.42M |
現金および同等物 | 79.86M | 121.72M | 93.41M | 136.43M | 131.58M | 99.22M | 60.49M | 147.22M |
非流動資産合計 | 28.88M | 28.01M | 27.17M | 26.62M | 26.19M | 25.93M | 25.59M | 36M |
負債合計 | 51.56M | 81.54M | 72.73M | 105.86M | 105.7M | 96.16M | 111.15M | 116.16M |
流動負債合計 | 28.71M | 22.32M | 19.48M | 22.25M | 25.43M | 22.86M | 23.54M | 28.9M |
非流動負債合計 | 41.58M | 91.52M | 85.07M | 115.45M | 134.59M | 127.87M | 142.43M | 162.29M |
普通株 | 69k | 122k | 122k | 164k | 165k | 167k | 168k | 168k |
留保所得 | -347.63M | -376.74M | -400.76M | -456.47M | -458.78M | -477.91M | -529.67M | -438.84M |
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総資産 | 7.6M | 81.25M | 36M | 160.7M | 122.87M | 117.18M | 155.59M | 147.26M |
流動資産合計 | 5.72M | 79.53M | 35.08M | 129.28M | 83.31M | 87.88M | 128.68M | 122.08M |
現金および同等物 | 3.04M | 76.79M | 30.75M | 126.18M | 78.71M | 81.79M | 121.72M | 99.22M |
非流動資産合計 | -56.56M | 58.71M | 21.6M | 129.22M | 72.8M | 64.41M | 74.05M | 51.1M |
負債合計 | 64.17M | 22.55M | 14.4M | 31.48M | 50.07M | 52.76M | 81.54M | 96.16M |
流動負債合計 | 12.06M | 10.68M | 5.4M | 9.45M | 11.95M | 14.02M | 22.32M | 22.86M |
非流動負債合計 | 62.23M | 21.79M | 16.9M | 42.13M | 71.3M | 71.88M | 91.52M | 127.87M |
総資本 | -56.56M | 58.71M | 21.6M | 129.22M | 72.8M | 64.41M | 74.05M | 51.1M |
普通株 | 1,000 | 15k | 15k | 16k | 16k | 28k | 122k | 167k |
留保所得 | -58.39M | -92.27M | -135.29M | -132.04M | -194.18M | -282.87M | -376.74M | -477.91M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約